世界の末梢神経炎治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Peripheral Neuritis Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5939
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、108ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、末梢神経炎治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（糖尿病性末梢神経障害（DPN）、化学療法誘発性末梢神経障害（CIPN）、特発性末梢神経障害（IPN）、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・末梢神経炎治療の市場動向
・企業の競争状況、市場シェア
・末梢神経炎治療の種類別市場規模と予測2016-2027（糖尿病性末梢神経障害（DPN）、化学療法誘発性末梢神経障害（CIPN）、特発性末梢神経障害（IPN）、その他）
・末梢神経炎治療の用途別市場規模と予測2016-2027（病院薬局、小売薬局、オンライン薬局）
・末梢神経炎治療の北米市場規模2016-2027（アメリカ、カナダ）
・末梢神経炎治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・末梢神経炎治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・末梢神経炎治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・末梢神経炎治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Pfizer、Depomed、Novartis、Biogen、GlaxoSmithKline、Sanofi、Eli Lilly and Company、Bristol-Myers Squibb、Baxter Healthcare、Johnson & Johnson、Teva Pharmaceuticals）
・結論

Peripheral neuropathy is a syndrome caused by sensory loss, muscle weakness and atrophy, decreased tendon reflexes, and vasomotor symptoms, alone or in any combination. Of all the options for the treatment of peripheral neuritis, analgesics and local anesthetics are the first line of treatment to relieve the inflammation of peripheral nerves.

Market Analysis and Insights: Global Peripheral Neuritis Treatment Market
The global Peripheral Neuritis Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Peripheral Neuritis Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Peripheral Neuritis Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Peripheral Neuritis Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Peripheral Neuritis Treatment market.

Global Peripheral Neuritis Treatment Scope and Market Size
Peripheral Neuritis Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Peripheral Neuritis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Diabetic Peripheral Neuropathy (DPN)
Chemotherapy-induced Peripheral Neuropathy (CIPN)
Idiopathic Peripheral Neuropathy (IPN)
Others

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Depomed
Novartis
Biogen
GlaxoSmithKline
Sanofi
Eli Lilly and Company
Bristol-Myers Squibb
Baxter Healthcare
Johnson & Johnson
Teva Pharmaceuticals

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peripheral Neuritis Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Diabetic Peripheral Neuropathy (DPN)
1.2.3 Chemotherapy-induced Peripheral Neuropathy (CIPN)
1.2.4 Idiopathic Peripheral Neuropathy (IPN)
1.2.5 Others
1.3 Market by Application
1.3.1 Global Peripheral Neuritis Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Peripheral Neuritis Treatment Market Perspective (2016-2027)
2.2 Peripheral Neuritis Treatment Growth Trends by Regions
2.2.1 Peripheral Neuritis Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Peripheral Neuritis Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Peripheral Neuritis Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Peripheral Neuritis Treatment Industry Dynamic
2.3.1 Peripheral Neuritis Treatment Market Trends
2.3.2 Peripheral Neuritis Treatment Market Drivers
2.3.3 Peripheral Neuritis Treatment Market Challenges
2.3.4 Peripheral Neuritis Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Peripheral Neuritis Treatment Players by Revenue
3.1.1 Global Top Peripheral Neuritis Treatment Players by Revenue (2016-2021)
3.1.2 Global Peripheral Neuritis Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Peripheral Neuritis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Peripheral Neuritis Treatment Revenue
3.4 Global Peripheral Neuritis Treatment Market Concentration Ratio
3.4.1 Global Peripheral Neuritis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peripheral Neuritis Treatment Revenue in 2020
3.5 Peripheral Neuritis Treatment Key Players Head office and Area Served
3.6 Key Players Peripheral Neuritis Treatment Product Solution and Service
3.7 Date of Enter into Peripheral Neuritis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Peripheral Neuritis Treatment Breakdown Data by Type
4.1 Global Peripheral Neuritis Treatment Historic Market Size by Type (2016-2021)
4.2 Global Peripheral Neuritis Treatment Forecasted Market Size by Type (2022-2027)

5 Peripheral Neuritis Treatment Breakdown Data by Application
5.1 Global Peripheral Neuritis Treatment Historic Market Size by Application (2016-2021)
5.2 Global Peripheral Neuritis Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Peripheral Neuritis Treatment Market Size (2016-2027)
6.2 North America Peripheral Neuritis Treatment Market Size by Type
6.2.1 North America Peripheral Neuritis Treatment Market Size by Type (2016-2021)
6.2.2 North America Peripheral Neuritis Treatment Market Size by Type (2022-2027)
6.2.3 North America Peripheral Neuritis Treatment Market Size by Type (2016-2027)
6.3 North America Peripheral Neuritis Treatment Market Size by Application
6.3.1 North America Peripheral Neuritis Treatment Market Size by Application (2016-2021)
6.3.2 North America Peripheral Neuritis Treatment Market Size by Application (2022-2027)
6.3.3 North America Peripheral Neuritis Treatment Market Size by Application (2016-2027)
6.4 North America Peripheral Neuritis Treatment Market Size by Country
6.4.1 North America Peripheral Neuritis Treatment Market Size by Country (2016-2021)
6.4.2 North America Peripheral Neuritis Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Peripheral Neuritis Treatment Market Size (2016-2027)
7.2 Europe Peripheral Neuritis Treatment Market Size by Type
7.2.1 Europe Peripheral Neuritis Treatment Market Size by Type (2016-2021)
7.2.2 Europe Peripheral Neuritis Treatment Market Size by Type (2022-2027)
7.2.3 Europe Peripheral Neuritis Treatment Market Size by Type (2016-2027)
7.3 Europe Peripheral Neuritis Treatment Market Size by Application
7.3.1 Europe Peripheral Neuritis Treatment Market Size by Application (2016-2021)
7.3.2 Europe Peripheral Neuritis Treatment Market Size by Application (2022-2027)
7.3.3 Europe Peripheral Neuritis Treatment Market Size by Application (2016-2027)
7.4 Europe Peripheral Neuritis Treatment Market Size by Country
7.4.1 Europe Peripheral Neuritis Treatment Market Size by Country (2016-2021)
7.4.2 Europe Peripheral Neuritis Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Peripheral Neuritis Treatment Market Size (2016-2027)
8.2 Asia-Pacific Peripheral Neuritis Treatment Market Size by Type
8.2.1 Asia-Pacific Peripheral Neuritis Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Peripheral Neuritis Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Peripheral Neuritis Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Peripheral Neuritis Treatment Market Size by Application
8.3.1 Asia-Pacific Peripheral Neuritis Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Peripheral Neuritis Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Peripheral Neuritis Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Peripheral Neuritis Treatment Market Size by Region
8.4.1 Asia-Pacific Peripheral Neuritis Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Peripheral Neuritis Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Peripheral Neuritis Treatment Market Size (2016-2027)
9.2 Latin America Peripheral Neuritis Treatment Market Size by Type
9.2.1 Latin America Peripheral Neuritis Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Peripheral Neuritis Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Peripheral Neuritis Treatment Market Size by Type (2016-2027)
9.3 Latin America Peripheral Neuritis Treatment Market Size by Application
9.3.1 Latin America Peripheral Neuritis Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Peripheral Neuritis Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Peripheral Neuritis Treatment Market Size by Application (2016-2027)
9.4 Latin America Peripheral Neuritis Treatment Market Size by Country
9.4.1 Latin America Peripheral Neuritis Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Peripheral Neuritis Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Peripheral Neuritis Treatment Market Size (2016-2027)
10.2 Middle East & Africa Peripheral Neuritis Treatment Market Size by Type
10.2.1 Middle East & Africa Peripheral Neuritis Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Peripheral Neuritis Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Peripheral Neuritis Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Peripheral Neuritis Treatment Market Size by Application
10.3.1 Middle East & Africa Peripheral Neuritis Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Peripheral Neuritis Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Peripheral Neuritis Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Peripheral Neuritis Treatment Market Size by Country
10.4.1 Middle East & Africa Peripheral Neuritis Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Peripheral Neuritis Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Peripheral Neuritis Treatment Introduction
11.1.4 Pfizer Revenue in Peripheral Neuritis Treatment Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Depomed
11.2.1 Depomed Company Details
11.2.2 Depomed Business Overview
11.2.3 Depomed Peripheral Neuritis Treatment Introduction
11.2.4 Depomed Revenue in Peripheral Neuritis Treatment Business (2016-2021)
11.2.5 Depomed Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Peripheral Neuritis Treatment Introduction
11.3.4 Novartis Revenue in Peripheral Neuritis Treatment Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Biogen
11.4.1 Biogen Company Details
11.4.2 Biogen Business Overview
11.4.3 Biogen Peripheral Neuritis Treatment Introduction
11.4.4 Biogen Revenue in Peripheral Neuritis Treatment Business (2016-2021)
11.4.5 Biogen Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Peripheral Neuritis Treatment Introduction
11.5.4 GlaxoSmithKline Revenue in Peripheral Neuritis Treatment Business (2016-2021)
11.5.5 GlaxoSmithKline Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Details
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Peripheral Neuritis Treatment Introduction
11.6.4 Sanofi Revenue in Peripheral Neuritis Treatment Business (2016-2021)
11.6.5 Sanofi Recent Development
11.7 Eli Lilly and Company
11.7.1 Eli Lilly and Company Company Details
11.7.2 Eli Lilly and Company Business Overview
11.7.3 Eli Lilly and Company Peripheral Neuritis Treatment Introduction
11.7.4 Eli Lilly and Company Revenue in Peripheral Neuritis Treatment Business (2016-2021)
11.7.5 Eli Lilly and Company Recent Development
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Company Details
11.8.2 Bristol-Myers Squibb Business Overview
11.8.3 Bristol-Myers Squibb Peripheral Neuritis Treatment Introduction
11.8.4 Bristol-Myers Squibb Revenue in Peripheral Neuritis Treatment Business (2016-2021)
11.8.5 Bristol-Myers Squibb Recent Development
11.9 Baxter Healthcare
11.9.1 Baxter Healthcare Company Details
11.9.2 Baxter Healthcare Business Overview
11.9.3 Baxter Healthcare Peripheral Neuritis Treatment Introduction
11.9.4 Baxter Healthcare Revenue in Peripheral Neuritis Treatment Business (2016-2021)
11.9.5 Baxter Healthcare Recent Development
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Details
11.10.2 Johnson & Johnson Business Overview
11.10.3 Johnson & Johnson Peripheral Neuritis Treatment Introduction
11.10.4 Johnson & Johnson Revenue in Peripheral Neuritis Treatment Business (2016-2021)
11.10.5 Johnson & Johnson Recent Development
11.11 Teva Pharmaceuticals
11.11.1 Teva Pharmaceuticals Company Details
11.11.2 Teva Pharmaceuticals Business Overview
11.11.3 Teva Pharmaceuticals Peripheral Neuritis Treatment Introduction
11.11.4 Teva Pharmaceuticals Revenue in Peripheral Neuritis Treatment Business (2016-2021)
11.11.5 Teva Pharmaceuticals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Peripheral Neuritis Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Diabetic Peripheral Neuropathy (DPN)
Table 3. Key Players of Chemotherapy-induced Peripheral Neuropathy (CIPN)
Table 4. Key Players of Idiopathic Peripheral Neuropathy (IPN)
Table 5. Key Players of Others
Table 6. Global Peripheral Neuritis Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Peripheral Neuritis Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Peripheral Neuritis Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Peripheral Neuritis Treatment Market Share by Regions (2016-2021)
Table 10. Global Peripheral Neuritis Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Peripheral Neuritis Treatment Market Share by Regions (2022-2027)
Table 12. Peripheral Neuritis Treatment Market Trends
Table 13. Peripheral Neuritis Treatment Market Drivers
Table 14. Peripheral Neuritis Treatment Market Challenges
Table 15. Peripheral Neuritis Treatment Market Restraints
Table 16. Global Peripheral Neuritis Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Peripheral Neuritis Treatment Market Share by Players (2016-2021)
Table 18. Global Top Peripheral Neuritis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peripheral Neuritis Treatment as of 2020)
Table 19. Ranking of Global Top Peripheral Neuritis Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Peripheral Neuritis Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Peripheral Neuritis Treatment Product Solution and Service
Table 23. Date of Enter into Peripheral Neuritis Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Peripheral Neuritis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Peripheral Neuritis Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Peripheral Neuritis Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Peripheral Neuritis Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Peripheral Neuritis Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Peripheral Neuritis Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Peripheral Neuritis Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Peripheral Neuritis Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Peripheral Neuritis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Peripheral Neuritis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Peripheral Neuritis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Peripheral Neuritis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Peripheral Neuritis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Peripheral Neuritis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Peripheral Neuritis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Peripheral Neuritis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Peripheral Neuritis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Peripheral Neuritis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Peripheral Neuritis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Peripheral Neuritis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Peripheral Neuritis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Peripheral Neuritis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Peripheral Neuritis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Peripheral Neuritis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Peripheral Neuritis Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Peripheral Neuritis Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Peripheral Neuritis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Peripheral Neuritis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Peripheral Neuritis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Peripheral Neuritis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Peripheral Neuritis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Peripheral Neuritis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Peripheral Neuritis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Peripheral Neuritis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Peripheral Neuritis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Peripheral Neuritis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Peripheral Neuritis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Peripheral Neuritis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Pfizer Company Details
Table 64. Pfizer Business Overview
Table 65. Pfizer Peripheral Neuritis Treatment Product
Table 66. Pfizer Revenue in Peripheral Neuritis Treatment Business (2016-2021) & (US$ Million)
Table 67. Pfizer Recent Development
Table 68. Depomed Company Details
Table 69. Depomed Business Overview
Table 70. Depomed Peripheral Neuritis Treatment Product
Table 71. Depomed Revenue in Peripheral Neuritis Treatment Business (2016-2021) & (US$ Million)
Table 72. Depomed Recent Development
Table 73. Novartis Company Details
Table 74. Novartis Business Overview
Table 75. Novartis Peripheral Neuritis Treatment Product
Table 76. Novartis Revenue in Peripheral Neuritis Treatment Business (2016-2021) & (US$ Million)
Table 77. Novartis Recent Development
Table 78. Biogen Company Details
Table 79. Biogen Business Overview
Table 80. Biogen Peripheral Neuritis Treatment Product
Table 81. Biogen Revenue in Peripheral Neuritis Treatment Business (2016-2021) & (US$ Million)
Table 82. Biogen Recent Development
Table 83. GlaxoSmithKline Company Details
Table 84. GlaxoSmithKline Business Overview
Table 85. GlaxoSmithKline Peripheral Neuritis Treatment Product
Table 86. GlaxoSmithKline Revenue in Peripheral Neuritis Treatment Business (2016-2021) & (US$ Million)
Table 87. GlaxoSmithKline Recent Development
Table 88. Sanofi Company Details
Table 89. Sanofi Business Overview
Table 90. Sanofi Peripheral Neuritis Treatment Product
Table 91. Sanofi Revenue in Peripheral Neuritis Treatment Business (2016-2021) & (US$ Million)
Table 92. Sanofi Recent Development
Table 93. Eli Lilly and Company Company Details
Table 94. Eli Lilly and Company Business Overview
Table 95. Eli Lilly and Company Peripheral Neuritis Treatment Product
Table 96. Eli Lilly and Company Revenue in Peripheral Neuritis Treatment Business (2016-2021) & (US$ Million)
Table 97. Eli Lilly and Company Recent Development
Table 98. Bristol-Myers Squibb Company Details
Table 99. Bristol-Myers Squibb Business Overview
Table 100. Bristol-Myers Squibb Revenue in Peripheral Neuritis Treatment Business (2016-2021) & (US$ Million)
Table 101. Bristol-Myers Squibb Recent Development
Table 102. Baxter Healthcare Company Details
Table 103. Baxter Healthcare Business Overview
Table 104. Baxter Healthcare Peripheral Neuritis Treatment Product
Table 105. Baxter Healthcare Revenue in Peripheral Neuritis Treatment Business (2016-2021) & (US$ Million)
Table 106. Baxter Healthcare Recent Development
Table 107. Johnson & Johnson Company Details
Table 108. Johnson & Johnson Business Overview
Table 109. Johnson & Johnson Peripheral Neuritis Treatment Product
Table 110. Johnson & Johnson Revenue in Peripheral Neuritis Treatment Business (2016-2021) & (US$ Million)
Table 111. Johnson & Johnson Recent Development
Table 112. Teva Pharmaceuticals Company Details
Table 113. Teva Pharmaceuticals Business Overview
Table 114. Teva Pharmaceuticals Peripheral Neuritis Treatment Product
Table 115. Teva Pharmaceuticals Revenue in Peripheral Neuritis Treatment Business (2016-2021) & (US$ Million)
Table 116. Teva Pharmaceuticals Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Peripheral Neuritis Treatment Market Share by Type: 2020 VS 2027
Figure 2. Diabetic Peripheral Neuropathy (DPN) Features
Figure 3. Chemotherapy-induced Peripheral Neuropathy (CIPN) Features
Figure 4. Idiopathic Peripheral Neuropathy (IPN) Features
Figure 5. Others Features
Figure 6. Global Peripheral Neuritis Treatment Market Share by Application: 2020 VS 2027
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Peripheral Neuritis Treatment Report Years Considered
Figure 11. Global Peripheral Neuritis Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Peripheral Neuritis Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Peripheral Neuritis Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Peripheral Neuritis Treatment Market Share by Regions (2022-2027)
Figure 15. Global Peripheral Neuritis Treatment Market Share by Players in 2020
Figure 16. Global Top Peripheral Neuritis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peripheral Neuritis Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Peripheral Neuritis Treatment Revenue in 2020
Figure 18. Global Peripheral Neuritis Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Peripheral Neuritis Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Peripheral Neuritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Peripheral Neuritis Treatment Market Share by Type (2016-2027)
Figure 22. North America Peripheral Neuritis Treatment Market Share by Application (2016-2027)
Figure 23. North America Peripheral Neuritis Treatment Market Share by Country (2016-2027)
Figure 24. United States Peripheral Neuritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Peripheral Neuritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Peripheral Neuritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Peripheral Neuritis Treatment Market Share by Type (2016-2027)
Figure 28. Europe Peripheral Neuritis Treatment Market Share by Application (2016-2027)
Figure 29. Europe Peripheral Neuritis Treatment Market Share by Country (2016-2027)
Figure 30. Germany Peripheral Neuritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Peripheral Neuritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Peripheral Neuritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Peripheral Neuritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Peripheral Neuritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Peripheral Neuritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Peripheral Neuritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Peripheral Neuritis Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Peripheral Neuritis Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Peripheral Neuritis Treatment Market Share by Region (2016-2027)
Figure 40. China Peripheral Neuritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Peripheral Neuritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Peripheral Neuritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Peripheral Neuritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Peripheral Neuritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Peripheral Neuritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Peripheral Neuritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Peripheral Neuritis Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Peripheral Neuritis Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Peripheral Neuritis Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Peripheral Neuritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Peripheral Neuritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Peripheral Neuritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Peripheral Neuritis Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Peripheral Neuritis Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Peripheral Neuritis Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Peripheral Neuritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Peripheral Neuritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Peripheral Neuritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Pfizer Revenue Growth Rate in Peripheral Neuritis Treatment Business (2016-2021)
Figure 60. Depomed Revenue Growth Rate in Peripheral Neuritis Treatment Business (2016-2021)
Figure 61. Novartis Revenue Growth Rate in Peripheral Neuritis Treatment Business (2016-2021)
Figure 62. Biogen Revenue Growth Rate in Peripheral Neuritis Treatment Business (2016-2021)
Figure 63. GlaxoSmithKline Revenue Growth Rate in Peripheral Neuritis Treatment Business (2016-2021)
Figure 64. Sanofi Revenue Growth Rate in Peripheral Neuritis Treatment Business (2016-2021)
Figure 65. Eli Lilly and Company Revenue Growth Rate in Peripheral Neuritis Treatment Business (2016-2021)
Figure 66. Bristol-Myers Squibb Revenue Growth Rate in Peripheral Neuritis Treatment Business (2016-2021)
Figure 67. Baxter Healthcare Revenue Growth Rate in Peripheral Neuritis Treatment Business (2016-2021)
Figure 68. Johnson & Johnson Revenue Growth Rate in Peripheral Neuritis Treatment Business (2016-2021)
Figure 69. Teva Pharmaceuticals Revenue Growth Rate in Peripheral Neuritis Treatment Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

以下、関連資料のご紹介

世界の視神経炎治療市場規模・現状・予測（2021年-2027年）

Global Optic Neuritis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5912 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、視神経炎治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（静脈注射、経口）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、...

世界の末梢神経損傷治療市場規模・現状・予測（2021年-2027年）

Global Peripheral Nerves Injury Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4686 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、末梢神経損傷治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（直接修理、神経移植、神経導管、その他）、用途別市場規模（神経縫合術、神経移植）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界の末梢T細胞リンパ腫（PTCL）治療市場規模・現状・予測（2021年-2027年）

Global Peripheral T-Cell Lymphoma (PTCL) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4687 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、末梢T細胞リンパ腫（PTCL）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、放射線療法、モノクローナル抗体療法、その他）、用途別市場規模（病院、クリニック、外来手術センター、その他）、...

世界の末梢神経修復＆再生市場規模・現状・予測（2021年-2027年）

Global Peripheral Nerve Repair and Re-generation Market Size, Status and Forecast 2021-2027
QFJ1-5297 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、末梢神経修復＆再生の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（人工神経、神経ラッピング、神経移植片、その他）、用途別市場規模（直接神経修復、神経移植）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の末梢骨密度測定市場規模・現状・予測（2021年-2027年）

Global Peripheral Bone Densitometry Market Size, Status and Forecast 2021-2027
QFJ1-5938 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、末梢骨密度測定の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（単一エネルギーX線吸収測定法（SEXA）、二重エネルギーX線吸収測定法（pDEXA）、放射線吸収測定法（RA）、定量的超音波（QUS）、末...

世界の末梢神経損傷手術市場規模・現状・予測（2021年-2027年）

Global Peripheral Nerves Injury Operative Market Size, Status and Forecast 2021-2027
QFJ1-4685 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、末梢神経損傷手術の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（外科的修復、神経移植）、用途別市場規模（神経縫合術、神経移植）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イン...

世界の末梢動脈血管再開通術市場規模・現状・予測（2021年-2027年）

Global Peripheral Artery Revascularisation Market Size, Status and Forecast 2021-2027
QFJ1-4684 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、末梢動脈血管再開通術の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（下肢血行再建術、腎動脈血行再建術、腸間膜動脈血行再建術、腹部大動脈血行再建術、その他）、用途別市場規模（病院、専門クリニック、その他...

世界の自転車周辺装置市場規模・現状・予測（2021年-2027年）

Global Bicycle Peripheral Market Size, Status and Forecast 2021-2027
QFJ1-2475 2021年6月 126Pages
QYResearch社発行の本調査レポートでは、自転車周辺装置の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（サイクリングウェア、ヘッドギア、プロテクションギア、ストレージユニット、ウェアラブルデバイス、アイウェア、アクセサリー、部品＆コンポーネン...

化学療法誘発性末梢神経障害治療のグローバル市場2021

Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales Market Report 2021
QAF27614 2021年3月23日 144Pages
本市場調査資料では、世界の化学療法誘発性末梢神経障害治療市場について種類別（カルシウムチャネルα2-デルタリガンド、抗うつ薬、オピオイド、その他）、用途別（プラチナ剤、タキサン、ビンカアルカロイド、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。...

世界の天然痘治療市場規模・現状・予測（2021年-2027年）

Global Smallpox Treatment Market Size, Status and Forecast 2021-2027
QFJ1-6015 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、天然痘治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（治療薬、ワクチン）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東...

化学療法誘発性末梢神経障害治療のグローバル市場2021 CIPN is a common adverse effect of several cancer therapies including taxanes and platinum drugs. Symptoms include decreased sensation and tingling of the hands and feet, severe pain, numbness and muscle weakness, all of which can occur during cancer treatment, and frequently persist after chemother…
世界の末梢神経損傷治療市場規模・現状・予測（2021年-2027年） When a nerve is cut due to a traumatic injury or surgery, functionality of the nerve may be compromised, causing the nerve to no longer carry the signals to and from the brain to the muscles and skin and reducing or eliminating functionality. Market Analysis and Insights: Global Peripheral Nerves In…
世界の末梢T細胞リンパ腫（PTCL）治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Peripheral T-Cell Lymphoma (PTCL) Treatment Market The global Peripheral T-Cell Lymphoma (PTCL) Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in …
世界の視神経炎治療市場規模・現状・予測（2021年-2027年） Optic neuritis is a general term for inflammation of any part of the optic nerve. It refers to inflammatory demyelination, infection and non-specific inflammation of the optic nerve. Market Analysis and Insights: Global Optic Neuritis Treatment Market The global Optic Neuritis Treatment market size …
世界の末梢神経修復＆再生市場規模・現状・予測（2021年-2027年） Nerves can be damaged in a number of ways. When a nerve is cut due to a traumatic injury or surgery, functionality of the nerve may be compromised, causing the nerve to no longer carry the signals to and from the brain to the muscles and skin and reducing or eliminating functionality. Nerve damage o…